Galectin Therapeutics Inc Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -44.23M-1.08M-10.39M-9.88M-12.09M-16.23M-13.90M-13.29M-23.46M-30.66M-39.33M-40.63M-47.63M
Depreciation and Depletion 0.01M0.00M
Share-based Compensation 4.39M1.94M3.25M2.79M3.79M4.07M2.48M1.10M4.45M1.68M1.80M2.08M2.87M2.26M2.45M
Gains from Investment Securities 1.17M0.16M1.50M0.40M0.04M0.53M-0.56M0.43M-0.59M
Asset Writedowns and Impairment 0.34M0.01M
Cash from Operations -42.27M-3.10M-5.68M-7.50M-7.48M-12.43M-16.41M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-33.00M-41.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.04M0.04M0.03M0.03M0.04M
Amortization of Deferred Charges 4.28M0.00M0.01M0.34M0.09M0.09M0.28M0.41M0.70M1.10M
Depreciation & Amortization (CF) 0.53M0.01M0.01M0.01M0.01M0.01M0.01M0.00M
Change in Working Capital
Change in Receivables 0.23M-0.23M
Change in Accured Expenses 1.07M-0.14M1.27M-0.58M0.85M-0.78M2.42M-0.81M-1.09M1.00M2.54M3.69M4.24M2.67M4.44M
Other Working Capital Changes -0.29M0.03M0.06M0.04M0.34M-0.12M-0.01M-0.02M0.36M1.59M-0.07M-0.10M0.09M0.08M
Investing Activities
Capital Expenditures -0.42M-0.00M0.01M0.01M
Cash from Investing Activities -0.88M-0.00M-0.01M0.06M-0.40M
Financing Activities
Other financing activities -0.00M0.00M
Cash from Financing Activities 43.41M8.74M6.20M10.40M8.61M31.46M5.92M3.58M15.38M50.08M0.26M36.81M10.00M40.03M31.23M
Additional items
Change in Cash 0.25M5.64M0.51M2.97M1.12M18.64M-10.48M-12.31M5.20M39.23M-20.34M12.51M-21.06M7.07M-10.54M
Free Cash Flow -41.85M-3.10M-5.68M-7.50M-7.48M-12.43M-16.41M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-33.00M-41.80M
Net Cash Flow 0.25M5.64M0.51M2.97M1.12M18.64M-10.48M-12.31M5.20M39.23M-20.34M12.51M-21.06M7.03M-10.57M